pdufa.bio
CalendarConferencesAdCommDecisionsReadoutsResearchAccount
Home › PDUFA Calendar › RARE

RARE FDA calendar & decision history

Ultragenyx Pharmaceutical Inc. · 2 upcoming · 1 past FDA decision

Upcoming FDA catalysts

RARE · Aug 23, 2026DTX401 AAV gene therapy (pariglasgene brecaparvovec) — Glycogen Storage Disease Type Ia (GSDIa)RARE · Sep 19, 2026UX111 - (ABO-102) — Sanfilippo syndrome type A (MPS IIIA)

FDA decision history (1)

Jul 11, 2025✕ CRLFDA decision
Full PDUFA calendar →All FDA decisions →Phase readouts →
See the full 2026 PDUFA calendar →

This page aggregates RARE's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.